FreeFunding Opportunities DoD Rare Cancers Research Program funding opportunities for FY21 May 28, 2021Vol.47 No.21
Clinical RoundupFree ACCC report: COVID-19 took a heavy toll on cancer care staff and providers May 28, 2021Vol.47 No.21
Clinical RoundupFree UVA develops tools to advance genomics, cancer research May 28, 2021Vol.47 No.21
Drugs & TargetsFree Rybrevant receives FDA approval as first targeted therapy for subset of NSCLC May 28, 2021Vol.47 No.21
Drugs & TargetsFree Pylarify receives FDA approval as first and only commercially available PSMA PET imaging agent for prostate cancer May 28, 2021Vol.47 No.21
Drugs & TargetsFree Opdivo + Yervoy receives Positive CHMP Opinion for colorectal cancer May 28, 2021Vol.47 No.21
Drugs & TargetsFree Keytruda receives Positive EU CHMP Opinion in combination with chemotherapy as first-line treatment for certain patients with esophageal cancer or HER2- GEJ adenocarcinoma May 28, 2021Vol.47 No.21
Drugs & TargetsFree Venclyxto receives EC approval in combination with a hypomethylating agent for patients with newly diagnosed aml who are ineligible for intensive chemotherapy May 28, 2021Vol.47 No.21
Drugs & TargetsFree Quest Diagnostics, Paige collaborate to advance AI-generated pathology insights to improve cancer diagnosis and care May 28, 2021Vol.47 No.21
